Iso-seco-tanapartholide activates Nrf2 signaling pathway through Keap1 modification and oligomerization to exert anti-inflammatory effects.
Iso-seco-tanapartholide activates Nrf2 signaling pathway through Keap1 modification and oligomerization to exert anti-inflammatory effects.
复制标题
DOI:
10.1016/j.freeradbiomed.2021.12.259
复制
发表时间:
2021-12
影响因子:
7.4
通讯作者:
Dongrong Zhu;Yuan-zheng Xia;Shun-Jie Li;Min-yi Kong;Chen Chen-Chen;Guimin Xue;L. Kong;Jianguang Luo-
中科院分区:
文献类型:
--
作者:
Dongrong Zhu;Yuan-zheng Xia;Shun-Jie Li;Min-yi Kong;Chen Chen-Chen;Guimin Xue;L. Kong;Jianguang Luo-
Covalent modification of Keap1 results in reducing ubiquitination and the accumulation of Nrf2, which subsequently initiates the transcription of cellular anti-oxidant and anti-inflammatory genes. Iso-seco-tanapartholide (IST), a sesquiterpene isolated from the traditional Chinese medicineArtemisiaargyi, had been reported to possess NF-κB inhibitory activity. However, its deep anti-inflammatory effects and direct target have never been reported. Here we show that IST activated Nrf2 and increased its target gene expression. In particular, LPS-caused inflammationin vitroandin vivowas mitigated by IST-induced Nrf2 activation but aggravated by Nrf2 inhibition. Mechanically, IST targeted Keap1 proteins via alkylating its cysteine residues 151, 273, 288, and so on. Subsequently, the modifying agent IST was displaced by intermolecular sulfhydryl disulfide interchange to lead to a disulfide dimer of Keap1. The resulting conformational change of Keap1 liberated Nrf2 from sequestration and allowed it translocation to the nucleus to activate the transcriptional program. Further studies demonstrated that Keap1 dimer formation contributed to the anti-inflammatory effects of IST. Taken together, our findings reveal a new mechanism for Nrf2 activation and provide a potential lead compound to treat inflammatory diseases through targeting Keap1.